VIJENDRA SINGH M.D.
Prescription History 1487034021
Internal Medicine - Hematology & Oncology in Detroit, MI
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for VIJENDRA SINGH M.D., an active Hematology & Oncology specialist practicing in Detroit, MI. Our medical registry currently tracks 16 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 312 documented patient claims. Among these therapy options, the most frequently utilized medication is Oxycodone Hcl, which accounts for 38 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MI PrescribersVs. MI Avg |
|---|---|---|---|
| Oxycodone Hcl | 38 | $39.45 | ≈ Typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 38 Medicare prescriptions for Oxycodone Hcl, about the same volume as the typical Michigan prescriber of this medication (41.1). Medicare paid an average of $39.45 per fill, versus $13.27 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38 30-Day Fills standardized to 30-day supplies 931 Days of Medication total across all patients in 2024 | |||
| CalquenceAcalabrutinib Maleate | 29 | $18,455.97 | ≈ Typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. Inhibits Bruton’s tyrosine kinase; has antineoplastic activity. In 2024, this provider wrote 29 Medicare prescriptions for Calquence, about the same volume as the typical Michigan prescriber of this medication (28.2). Medicare paid an average of $18,455.97 per fill, versus $13,917.90 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2024 | |||
| BosulifBosutinib | 26 | $10,769.60▼ below MI avg | ▲ More than typical |
About Bosulif: Bosutinib is used to treat a certain type of blood cancer (chronic myelogenous leukemia-CML). Show more ▾ It works by slowing or stopping the growth of cancer cells. A 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases. In 2024, this provider wrote 26 Medicare prescriptions for Bosulif, about 1.3 times the volume of the typical Michigan prescriber of this medication (19.7). Medicare paid an average of $10,769.60 per fill, versus $14,642.49 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 26 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2024 | |||
| EliquisApixaban | 25 | $957.65 | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 25 Medicare prescriptions for Eliquis, about a third of the volume of the typical Michigan prescriber of this medication (86.7). Medicare paid an average of $957.65 per fill, versus $945.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 41 30-Day Fills standardized to 30-day supplies 1,228 Days of Medication total across all patients in 2024 | |||
| Imatinib Mesylate | 23 | $1,618.75 | ≈ Typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2024, this provider wrote 23 Medicare prescriptions for Imatinib Mesylate, about 82% of the volume of the typical Michigan prescriber of this medication (28.2). Medicare paid an average of $1,618.75 per fill, versus $890.92 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 690 Days of Medication total across all patients in 2024 | |||
| Acyclovir | 22 | $20.53 | ≈ Typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2024, this provider wrote 22 Medicare prescriptions for Acyclovir, about 82% of the volume of the typical Michigan prescriber of this medication (26.8). Medicare paid an average of $20.53 per fill, versus $17.93 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 41 30-Day Fills standardized to 30-day supplies 1,222 Days of Medication total across all patients in 2024 | |||
| Hydroxyurea | 22 | $27.95▼ below MI avg | ▼ Less than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2024, this provider wrote 22 Medicare prescriptions for Hydroxyurea, about half the volume of the typical Michigan prescriber of this medication (41.1). Medicare paid an average of $27.95 per fill, versus $30.68 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 30 30-Day Fills standardized to 30-day supplies 877 Days of Medication total across all patients in 2024 | |||
| RevlimidLenalidomide | 20 | $18,115.75 | ▼ Less than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2024, this provider wrote 20 Medicare prescriptions for Revlimid, about half the volume of the typical Michigan prescriber of this medication (46.2). Medicare paid an average of $18,115.75 per fill, versus $17,721.20 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 560 Days of Medication total across all patients in 2024 | |||
| SprycelDasatinib | 20 | $14,197.21 | ≈ Typical |
About Sprycel: This medication is used to treat certain types of cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL). Show more ▾ It works by slowing or stopping the growth of cancer cells. A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB. In 2024, this provider wrote 20 Medicare prescriptions for Sprycel, about the same volume as the typical Michigan prescriber of this medication (19.3). Medicare paid an average of $14,197.21 per fill, versus $12,744.54 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Ondansetron Hcl | 14 | $4.32▼ below MI avg | ▼ Less than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 14 Medicare prescriptions for Ondansetron Hcl, about half the volume of the typical Michigan prescriber of this medication (28.1). Medicare paid an average of $4.32 per fill, versus $13.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 14 30-Day Fills standardized to 30-day supplies 192 Days of Medication total across all patients in 2024 | |||
| ImbruvicaIbrutinib | 13 | $16,141.93 | ▼ Less than typical |
About Imbruvica: This medication is used to treat certain cancers (such as chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). A Btk protein inhibitor. In 2024, this provider wrote 13 Medicare prescriptions for Imbruvica, about a third of the volume of the typical Michigan prescriber of this medication (32.6). Medicare paid an average of $16,141.93 per fill, versus $15,685.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2024 | |||
| OxycontinOxycodone Hcl | 13 | $3,548.49 | ▼ Less than typical |
About Oxycontin: This medication is used to help relieve severe ongoing pain (such as due to cancer). Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (more than 40 milligrams per tablet) should be used only if you have been regularly taking moderate to large amounts of an opioid pain medication. These strengths may cause overdose (even death) if taken by a person who has not been regularly taking opioids. Do not use the extended-release form of oxycodone to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 13 Medicare prescriptions for Oxycontin, about half the volume of the typical Michigan prescriber of this medication (23.7). Medicare paid an average of $3,548.49 per fill, versus $818.13 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 367 Days of Medication total across all patients in 2024 | |||
| Pantoprazole Sodium | 13 | $4.90▼ below MI avg | ▼ Less than typical |
About Pantoprazole Sodium: Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Show more ▾ It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER. In 2024, this provider wrote 13 Medicare prescriptions for Pantoprazole Sodium, about a quarter of the volume of the typical Michigan prescriber of this medication (64.6). Medicare paid an average of $4.90 per fill, versus $16.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2024 | |||
| Morphine Sulfate ErMorphine Sulfate | 12 | $30.45 | ▼ Less than typical |
About Morphine Sulfate Er: This medication is used to help relieve severe ongoing pain (such as due to cancer). Show more ▾ Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (100 milligrams or more per tablet) should be used only if you have been regularly taking moderate to large amounts of opioid pain medications. These strengths may cause overdose (even death) if taken by a person who has not been regularly taking opioids. Do not use the extended-release form of morphine to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use. The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. In 2024, this provider wrote 12 Medicare prescriptions for Morphine Sulfate Er, about a quarter of the volume of the typical Michigan prescriber of this medication (45). Medicare paid an average of $30.45 per fill, versus $29.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Deferasirox | 11 | $4,890.68 | ▼ Less than typical |
About Deferasirox: This medication is used to treat ongoing high levels of iron in the body caused by multiple blood transfusions. Show more ▾ It is also used to treat high levels of iron in people with a certain blood disorder who do not require blood transfusions (non-transfusion-dependent thalassemia). It works by binding to iron, allowing the body to pass extra iron out in the stool. Deferasirox belongs to a class of drugs known as iron-chelating agents. Frequent blood transfusions are often needed in certain types of blood diseases (such as sickle cell disease, anemia). Blood transfusions have very helpful benefits, but they can cause the body to hold on to too much iron. The extra iron can build up in the body and cause problems such as heart failure, liver disease, and diabetes. Getting rid of extra iron can decrease the risk of these diseases. A triazole and benzoate derivative that acts as a selective iron chelator. It is used in the management of chronic IRON OVERLOAD due to blood transfusion or non-transfusion dependent THALASSEMIA. In 2024, this provider wrote 11 Medicare prescriptions for Deferasirox, about 65% of the volume of the typical Michigan prescriber of this medication (17). Medicare paid an average of $4,890.68 per fill, versus $1,640.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
| Potassium Chloride | 11 | $9.18▼ below MI avg | ▼ Less than typical |
About Potassium Chloride: This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. Show more ▾ A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics. A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. In 2024, this provider wrote 11 Medicare prescriptions for Potassium Chloride, about 19% of the volume of the typical Michigan prescriber of this medication (58.5). Medicare paid an average of $9.18 per fill, versus $23.31 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 20 30-Day Fills standardized to 30-day supplies 533 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for VIJENDRA SINGH M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Detroit, MI practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MI prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
